As of January 22, 2025, DBV Technologies (DBVT) has a market cap of $0.10 billion USD. According to our data, DBV Technologies is ranked No.7673 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.10 B |
60.44%
|
Dec 31, 2024 | $63.40 M |
62.12%
|
Dec 29, 2023 | $39.10 M |
-37.71%
|
Dec 30, 2022 | $62.78 M |
-4.38%
|
Dec 31, 2021 | $65.65 M |
-38.93%
|
Dec 31, 2020 | $0.11 B |
-75.51%
|
Dec 31, 2019 | $0.44 B |
66.67%
|
Dec 31, 2018 | $0.26 B |
-73.90%
|
Dec 29, 2017 | $1.01 B |
-29.97%
|
Dec 30, 2016 | $1.44 B |
-3.25%
|
Dec 31, 2015 | $1.49 B |
33.89%
|
Dec 31, 2014 | $1.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Market Cap | = | DBVT Stock Price | * | DBVT Shares Outstanding |
= | $4.74 | * | 20.52 M | |
= | $0.10 B |